Safety and efficacy of tesofensine/metoprolol in subjects with Prader-Willi syndrome
A double-blind, randomized, placebo-controlled, multiple-dose, multi-centre safety and efficacy study of co-administration of tesofensine/metoprolol in subjects with Prader-Willi syndrome (PWS) Second 12 weeks open label extension A double-blind, randomized, placebo-controlled, multiple-dose, multi-centre safety and efficacy stud ...